Renaissance Group LLC Horizon Therapeutics Public LTD CO Transaction History

Renaissance Group LLC

$2.36 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $121,349 - $141,897	-1,226 Reduced 23.84%	3,917 $453,000
Q2 2023 Aug 10, 2023	SELL	$96.34 - $112.38 $24.4 Million - $28.5 Million	-253,772 Reduced 98.01%	5,143 $528,000
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $2.98 Million - $3.15 Million	-27,725 Reduced 9.67%	258,915 $28.3 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $8.16 Million - $14.9 Million	-130,769 Reduced 31.33%	286,640 $32.6 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $7.01 Million - $10.1 Million	118,902 Added 39.83%	417,409 $25.8 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $93,533 - $137,072	-1,178 Reduced 0.39%	298,507 $23.8 Million
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $180,444 - $229,283	-2,088 Reduced 0.69%	299,685 $31.5 Million
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $1.06 Million - $1.29 Million	-10,740 Reduced 3.44%	301,773 $32.5 Million
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $253,579 - $304,510	-2,759 Reduced 0.88%	312,513 $34.2 Million
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $6.46 Million - $7.19 Million	-74,961 Reduced 19.21%	315,272 $29.5 Million
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $1.09 Million - $1.45 Million	-15,150 Reduced 3.74%	390,233 $35.9 Million
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $4.4 Million - $5.54 Million	-65,686 Reduced 13.94%	405,383 $29.7 Million
Q3 2020 Nov 12, 2020	SELL	$55.23 - $79.93 $2.61 Million - $3.78 Million	-47,284 Reduced 9.12%	471,069 $36.6 Million
Q2 2020 Aug 12, 2020	BUY	$30.2 - $56.98 $13.2 Million - $24.9 Million	437,270 Added 539.29%	518,353 $28.8 Million
Q1 2020 May 06, 2020	BUY	$24.87 - $38.56 $2.02 Million - $3.13 Million	81,083 New	81,083 $2.4 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Group LLC with notifications on news.

Account